See more : SJM Holdings Limited (0880.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Novartis India Limited (NOVARTIND.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Novartis India Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- PT Boston Furniture Industries Tbk (SOFA.JK) Income Statement Analysis – Financial Results
- Pono Capital Corp. (PONOU) Income Statement Analysis – Financial Results
- Kato Works Co.,Ltd. (6390.T) Income Statement Analysis – Financial Results
- Maxim Power Corp. (MXGFF) Income Statement Analysis – Financial Results
- Pyung Hwa Industrial Co., Ltd. (090080.KS) Income Statement Analysis – Financial Results
Novartis India Limited (NOVARTIND.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.novartis.in
About Novartis India Limited
Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.35B | 3.79B | 3.88B | 3.66B | 4.11B | 4.50B | 5.17B | 6.56B | 8.08B | 8.73B | 8.62B | 9.03B | 8.44B | 7.09B | 6.24B | 5.99B | 5.53B |
| Cost of Revenue | 2.02B | 2.02B | 1.81B | 1.50B | 1.85B | 2.02B | 2.50B | 3.11B | 3.50B | 3.53B | 3.93B | 3.72B | 3.14B | 2.73B | 2.51B | 2.52B | 2.46B |
| Gross Profit | 1.33B | 1.77B | 2.06B | 2.16B | 2.26B | 2.48B | 2.67B | 3.45B | 4.59B | 5.20B | 4.69B | 5.32B | 5.30B | 4.35B | 3.73B | 3.47B | 3.08B |
| Gross Profit Ratio | 39.60% | 46.75% | 53.18% | 59.07% | 54.94% | 55.12% | 51.71% | 52.54% | 56.74% | 59.59% | 54.41% | 58.86% | 62.75% | 61.41% | 59.74% | 57.89% | 55.63% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 232.40M | 64.20M | 67.80M | 54.60M | 72.00M | 89.10M | 71.10M | 78.80M | 89.90M | 0.00 | 0.00 | 0.00 | 397.90M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 19.40M | 279.80M | 356.60M | 397.70M | 539.90M | 602.90M | 724.80M | 729.60M | 451.50M | 0.00 | 0.00 | 0.00 | 931.50M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 251.80M | 344.00M | 424.40M | 452.30M | 611.90M | 692.00M | 795.90M | 808.40M | 541.40M | 0.00 | 0.00 | 0.00 | 1.33B | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 581.10M | 63.80M | 40.40M | 1.90M | 100.00K | 31.10M | 62.90M | 48.80M | 71.60M | 66.40M | 59.30M | 22.40M | 2.16B | 1.94B | 1.83B | 1.63B |
| Operating Expenses | 251.80M | 1.18B | 1.87B | 2.01B | 2.25B | 2.35B | 2.74B | 3.22B | 4.19B | 5.24B | 4.67B | 4.43B | 3.52B | 2.16B | 1.94B | 1.83B | 1.63B |
| Cost & Expenses | 2.25B | 3.19B | 3.68B | 3.51B | 4.10B | 4.37B | 5.24B | 6.34B | 7.68B | 8.77B | 8.60B | 8.14B | 6.67B | 4.90B | 4.45B | 4.35B | 4.08B |
| Interest Income | 553.40M | 545.00M | 212.30M | 244.50M | 359.30M | 470.30M | 1.47B | 632.50M | 723.30M | 796.50M | 810.90M | 744.60M | 729.30M | 522.50M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 14.90M | 17.50M | 48.30M | 76.80M | 63.90M | 15.90M | 55.30M | 7.20M | 2.10M | 106.30M | 2.70M | 2.20M | 5.40M | 2.80M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 26.10M | 60.60M | 96.50M | 121.60M | 131.40M | 31.80M | 25.30M | 35.90M | 36.70M | 40.10M | 36.50M | 35.90M | 26.70M | 23.82M | 22.51M | 26.88M | 28.50M |
| EBITDA | 652.60M | 1.23B | 106.60M | 598.80M | 481.70M | 158.30M | -59.00M | 250.40M | 426.30M | -304.80M | 737.80M | 976.60M | 1.46B | 2.22B | 1.81B | 4.21B | 5.55B |
| EBITDA Ratio | 19.48% | 32.62% | 14.60% | 15.15% | 11.72% | 13.27% | 28.17% | 14.62% | -15.05% | 9.81% | 0.68% | 10.27% | 27.27% | 31.21% | 29.03% | 27.85% | 26.75% |
| Operating Income | 1.10B | 600.80M | 237.70M | 168.70M | 8.40M | 131.00M | -65.70M | 223.00M | 401.20M | -36.90M | 22.70M | 891.40M | 1.78B | 2.19B | 1.79B | 1.64B | 1.45B |
| Operating Income Ratio | 32.81% | 15.86% | 6.13% | 4.61% | 0.20% | 2.91% | -1.27% | 3.40% | 4.96% | -0.42% | 0.26% | 9.87% | 21.05% | 30.88% | 28.67% | 27.40% | 26.23% |
| Total Other Income/Expenses | 129.20M | -193.80M | -222.00M | -758.60M | -987.40M | -571.90M | 1.64B | -745.80M | 781.30M | -2.34B | 681.00M | 802.80M | 470.00M | 944.00K | 8.73M | 35.38M | 48.29M |
| Income Before Tax | 1.23B | 1.15B | -38.20M | 400.40M | 286.40M | 857.70M | 1.58B | 917.30M | 2.81B | 918.60M | 899.00M | 1.69B | 2.25B | 2.19B | 1.80B | 1.73B | 1.54B |
| Income Before Tax Ratio | 36.66% | 30.46% | -0.99% | 10.95% | 6.96% | 19.05% | 30.46% | 13.98% | 34.82% | 10.52% | 10.43% | 18.75% | 26.61% | 30.89% | 28.81% | 28.84% | 27.88% |
| Income Tax Expense | 376.50M | 120.20M | -1.00M | 191.40M | 185.60M | 340.00M | 791.60M | 345.10M | 767.60M | 125.30M | -86.30M | 496.90M | 726.70M | 722.39M | 638.11M | 692.02M | 570.79M |
| Net Income | 851.90M | 1.03B | -37.20M | 209.00M | 100.80M | 517.70M | 783.60M | 572.20M | 1.99B | 791.10M | 985.30M | 1.20B | 1.52B | 1.47B | 1.16B | 1.04B | 972.35M |
| Net Income Ratio | 25.42% | 27.29% | -0.96% | 5.72% | 2.45% | 11.50% | 15.15% | 8.72% | 24.57% | 9.06% | 11.43% | 13.25% | 18.01% | 20.70% | 18.58% | 17.30% | 17.57% |
| EPS | 34.50 | 41.86 | -1.51 | 8.46 | 4.08 | 20.97 | 28.43 | 19.10 | 0.62 | 24.75 | 30.83 | 37.46 | 47.56 | 45.89 | 36.29 | 32.45 | 30.42 |
| EPS Diluted | 34.50 | 41.86 | -1.51 | 8.46 | 4.08 | 20.97 | 28.43 | 19.10 | 0.62 | 24.75 | 30.83 | 37.46 | 47.56 | 45.89 | 36.29 | 32.45 | 30.42 |
| Weighted Avg Shares Out | 24.69M | 24.69M | 24.69M | 24.69M | 24.69M | 24.69M | 27.56M | 29.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M |
| Weighted Avg Shares Out (Dil) | 24.69M | 24.69M | 24.69M | 24.69M | 24.69M | 24.69M | 27.56M | 29.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M |
Source: https://incomestatements.info
Category: Stock Reports